BFIM
GOSS icon

Beese Fulmer Investment Management’s Gossamer Bio GOSS Stock Holding History

Beese Fulmer Investment Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-139
Closed -$3.66K – 445
2026
Q1 		$3.66K Buy
+139
New +$17.5K ﹤0.01% 435

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Beese Fulmer Investment Management's GOSS Position: Q2 2026 in Review

Beese Fulmer Investment Management sold out of Gossamer Bio (GOSS) in Q2 2026, closing a stake of 139 shares — an estimated $3.66K sold.

Beese Fulmer Investment Management first reported a position in GOSS in Q1 2026 and held it in 1 quarter. The position peaked at $3.66K in Q1 2026. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Beese Fulmer Investment Management reported no remaining Gossamer Bio position as of Q2 2026 after selling out during the quarter.
  • Beese Fulmer Investment Management sold 139 Gossamer Bio shares in Q2 2026, an estimated $3.66K.
  • Beese Fulmer Investment Management first reported a position in Gossamer Bio in Q1 2026 and held it in 1 quarter.
  • Beese Fulmer Investment Management's Gossamer Bio position peaked at $3.66K in Q1 2026.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Beese Fulmer Investment Management's 13F filing for Q2 2026, filed 29 Jul 2026.